Bionomics Ltd Adr Stock Total Debt
| BNOX Stock | USD 0.30 0.02 7.14% |
Bionomics Ltd ADR fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Stock. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics stock.
Total Debt To Capitalization is likely to drop to 0 in 2024. Bionomics | Total Debt |
Bionomics Ltd ADR Company Total Debt Analysis
Bionomics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bionomics Total Debt | 272.74 K |
Most of Bionomics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bionomics Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Bionomics is extremely important. It helps to project a fair market value of Bionomics Stock properly, considering its historical fundamentals such as Total Debt. Since Bionomics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bionomics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bionomics' interrelated accounts and indicators.
Click cells to compare fundamentals
Bionomics Total Debt Historical Pattern
Today, most investors in Bionomics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bionomics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bionomics total debt as a starting point in their analysis.
Bionomics Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Bionomics Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Bionomics Ltd ADR has a Total Debt of 272.74 K. This is 99.99% lower than that of the Biotechnology sector and 99.92% lower than that of the Health Care industry. The total debt for all United States stocks is 99.99% higher than that of the company.
Bionomics Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in total debt category among its peers.
Bionomics Institutional Holders
Institutional Holdings refers to the ownership stake in Bionomics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bionomics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bionomics' value.| Shares | Armistice Capital, Llc | 2024-09-30 | 1.6 M | Xtx Topco Ltd | 2024-09-30 | 0.0 | Point72 Asset Management, L.p. | 2024-09-30 | 316 K | Ubs Group Ag | 2024-06-30 | 34.9 K | Two Sigma Securities, Llc | 2024-06-30 | 26 K | Beacon Pointe Advisors, Llc | 2024-06-30 | 10 K | Rhumbline Advisers | 2024-06-30 | 2.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 K | Aspire Private Capital, Llc | 2024-09-30 | 200 | Jpmorgan Chase & Co | 2024-06-30 | 1.0 | Two Sigma Investments Llc | 2024-09-30 | 0.0 |
Bionomics Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | 89.10 % | ||||
| Current Valuation | (2.01 M) | ||||
| Shares Outstanding | 19.53 M | ||||
| Shares Owned By Insiders | 33.91 % | ||||
| Shares Owned By Institutions | 16.22 % | ||||
| Number Of Shares Shorted | 384.28 K | ||||
| Price To Book | 0.34 X | ||||
| Price To Sales | 386.72 X | ||||
| Revenue | 20 K | ||||
| Gross Profit | (18.96 M) | ||||
| EBITDA | (9.84 M) | ||||
| Net Income | (15.49 M) | ||||
| Cash And Equivalents | 33.56 M | ||||
| Cash Per Share | 4.46 X | ||||
| Total Debt | 272.74 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 12.46 X | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (14.68 M) | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | (1.19) X | ||||
| Target Price | 15.37 | ||||
| Beta | -0.069 | ||||
| Market Capitalization | 5.82 M | ||||
| Total Asset | 18.96 M | ||||
| Retained Earnings | (177.98 M) | ||||
| Working Capital | 9.36 M | ||||
| Net Asset | 18.96 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.